Does reduced estradiol after menopause affect energy balance and body-fat distribution?

The transition through menopause is marked by a profound decline in circulating estradiol, which disrupts systemic energy balance and alters adipose tissue distribution.

Clinical evidence of metabolic remodeling

• Adipose redistribution: The postmenopausal decline in estradiol shifts body-fat distribution from a gynoid (subcutaneous) to an android (visceral abdominal) pattern. This accumulation of visceral fat is associated with heightened systemic inflammation and increased cardiometabolic risk.
• Energy expenditure shifts: Loss of estrogen receptor-alpha (ERα) signaling leads to a reduction in basal metabolic rate and spontaneous physical activity, which combines with increased appetite to promote a positive energy balance.

Mechanistic pathways

• Hypothalamic energy regulation: Under normal physiological conditions, estradiol binds to ERα in the ventromedial hypothalamus (VMH) to inhibit AMP-activated protein kinase (AMPK) activity. This inhibition activates sympathetic nervous system (SNS) drive to brown adipose tissue (BAT), stimulating thermogenesis. Postmenopausal loss of estradiol disinhibits VMH AMPK, suppressing this thermogenic pathway and reducing energy expenditure.
• Appetite control: Diminished ERα signaling on anorexigenic pro-opiomelanocortin (POMC) neurons in the arcuate nucleus (ARC) impairs satiety signaling, leading to increased food intake.
• Adipocyte receptor dynamics: Peripherally, estrogen signaling upregulates antilipolytic $\alpha_{2A}$-adrenergic receptors specifically on subcutaneous adipocytes, promoting gluteofemoral lipid storage. Deprived of this signaling, subcutaneous fat depots lose their capacity to act as a lipid sink, shifting deposition to visceral abdominal depots.

Bottom line

• Postmenopausal estrogen depletion directly drives visceral fat accumulation and reduced energy expenditure by impairing the hypothalamic VMH-AMPK-SNS-BAT thermogenic axis, suppressing central satiety pathways, and altering peripheral subcutaneous adipocyte receptor dynamics.